Azhar Ali
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Peroxisome Proliferator-Activated Receptors
- Ubiquitin and proteasome pathways
- Metabolism, Diabetes, and Cancer
- Metabolomics and Mass Spectrometry Studies
Papers in
-
- Cancer, Lipids, and Metabolism 4
- Cancer, Hypoxia, and Metabolism 3
- Cancer Genomics and Diagnostics 2
- Co-authors
- Chee Wai Fhu (4 shared papers)Tan Min Chin (3 shared papers)Elena Levantini (3 shared papers)Daniel G. Tenen (3 shared papers)John G. Clohessy (3 shared papers)Julian Goggi (2 shared papers)Leilei Chen (2 shared papers)Kishore Bhakoo (1 shared paper)
- Journals
- International Journal of Gynecological Cancer (2 papers)Breast Cancer Research and Treatment (2 papers)Theranostics (2 papers)Journal of Medicinal Chemistry (1 paper)iScience (1 paper)
- Partner nations
- SingaporeUnited StatesItaly
In The Last Decade
Azhar Ali
21 papers receiving 770 citations
Azhar Ali's Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 345
- Molecular Biology 421
- Biochemistry 44
- Applied Microbiology and Biotechnology 8
- Oncology 106
Countries citing papers authored by Azhar Ali
This map shows the geographic impact of Azhar Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azhar Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azhar Ali more than expected).
Fields of papers citing papers by Azhar Ali
This network shows the impact of papers produced by Azhar Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azhar Ali. The network helps show where Azhar Ali may publish in the future.
Co-authors
The 25 scholars most cited alongside Azhar Ali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fatty Acid Synthase: An Emerging Target in Cancer Hit paper breakdown → | 2020 | 292 |
| 2 | 2018 | 144 | |
| 3 | 2021 | 49 | |
| 4 | 2018 | 47 | |
| 5 | 2007 | 45 | |
| 6 | 2021 | 39 | |
| 7 | 2019 | 38 | |
| 8 | 2014 | 26 | |
| 9 | 2019 | 21 | |
| 10 | 2023 | 19 | |
| 11 | 2004 | 12 | |
| 12 | 2016 | 9 | |
| 13 | 2023 | 8 | |
| 14 | 2020 | 8 | |
| 15 | 2016 | 5 | |
| 16 | 2007 | 4 | |
| 17 | 2020 | 2 | |
| 18 | BRCA1 c.2845insA is a founder mutation in Singaporean Malay women with early onset breast/ovarian cancer. | 2003 | 2 |
| 19 | 2006 | 1 | |
| 20 | 2006 | 1 |
About Azhar Ali
Azhar Ali is a scholar working on Molecular Biology, Cancer Research, Genetics, Cell Biology and Genetics, having authored 24 papers that have together received 773 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (5 papers), Cancer, Lipids, and Metabolism (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Genomics and Diagnostics (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Cancer-related Molecular Pathways (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). The work is most often cited by research in Cancer Research (345 citations), Molecular Biology (421 citations), Biochemistry (44 citations), Applied Microbiology and Biotechnology (8 citations) and Oncology (106 citations). Azhar Ali has collaborated with scholars based in Singapore, United States and Italy. Frequent co-authors include Chee Wai Fhu, Tan Min Chin, Elena Levantini, Daniel G. Tenen, John G. Clohessy, Julian Goggi, Leilei Chen, Kishore Bhakoo, Olivier Kocher and Ross A. Soo. Their work appears in journals such as International Journal of Gynecological Cancer, Breast Cancer Research and Treatment, Theranostics, Journal of Medicinal Chemistry and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.